Case Report: Tumor-related hemorrhage determined treatment sequencing in blastic plasmacytoid dendritic cell neoplasm coexisting with gastric cardia adenocarcinoma - Scorecard - MDSpire

Case Report: Tumor-related hemorrhage determined treatment sequencing in blastic plasmacytoid dendritic cell neoplasm coexisting with gastric cardia adenocarcinoma

  • By

  • Yuze Li

  • Chenggong Zhang

  • Xudong Song

  • Guoquan Tao

  • May 1, 2026

  • 0 min

Share

Clinical Scorecard: Case Study: Management Sequence Influenced by Tumor-Associated Hemorrhage in Blastic Plasmacytoid Dendritic Cell Neoplasm Alongside Gastric Cardia Adenocarcinoma

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationOlder males diagnosed with BPDCN and presenting with gastrointestinal symptoms.
Care Setting

Key Highlights

  • Management of active tumor-related bleeding may take precedence over hematologic treatment due to the risk of severe complications.

Guideline-Based Recommendations

Diagnosis

  • Histopathological confirmation of BPDCN and secondary malignancies is essential, including markers such as CD4, CD56, CD123, and others relevant to gastric adenocarcinoma.

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Combination chemotherapy regimens may need adjustment based on specific concurrent malignancies and associated bleeding risks.

        Clinical Best Practices

        • Prioritize timely diagnosis and management of secondary malignancies in BPDCN patients.

        References

        Original Source(s)

        Related Content